These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9718119)

  • 1. Failure of SIVmac to be neutralized in macrophage cultures is unique to SIVmac and not observed with neutralization of SHIV or HIV-1.
    Zhuge W; Jia F; Stephens EB; Li Z; Wang C; Joag SV; Narayan O
    AIDS Res Hum Retroviruses; 1998 Aug; 14(12):1045-51. PubMed ID: 9718119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmas from lymphocyte- and macrophage-tropic SIVmac-infected macaques have antibodies with a broader spectrum of virus neutralization activity in macrophage versus lymphocyte cultures.
    Zhuge W; Jia F; Adany I; Narayan O; Stephens EB
    Virology; 1997 Jan; 227(1):24-33. PubMed ID: 9007055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization/enhancement of macrophage-tropic SIVmac infection by plasma from macaques infected with macrophage-tropic or lymphocyte-tropic SIVmac.
    Jolly PE; Huang L; Chen S
    Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):997-1008. PubMed ID: 11785666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in neutralization of simian lentivirus (SIVMAC) in lymphocyte and macrophage cultures.
    McEntee MF; Anderson MG; Daniel MD; Adams R; Farzadegan H; Desrosiers RC; Narayan O
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1193-8. PubMed ID: 1503828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralization sensitivity of a simian-human immunodeficiency virus (SHIV-HXBc2P 3.2N) isolated from an infected rhesus macaque with neurological disease.
    Song B; Cayabyab M; Phan N; Wang L; Axthelm MK; Letvin NL; Sodroski JG
    Virology; 2004 Apr; 322(1):168-81. PubMed ID: 15063126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of neutralizing antibodies against tier 2 human immunodeficiency virus 1 in rhesus macaques infected with tier 1B simian/human immunodeficiency virus.
    Himeno A; Ishida Y; Mori H; Matsuura K; Kikukawa M; Sakawaki H; Miura T
    Arch Virol; 2019 May; 164(5):1297-1308. PubMed ID: 30820667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1.
    Dunn CS; Hurtrel B; Beyer C; Gloeckler L; Ledger TN; Moog C; Kieny MP; Mehtali M; Schmitt D; Gut JP; Kirn A; Aubertin AM
    AIDS Res Hum Retroviruses; 1997 Jul; 13(11):913-22. PubMed ID: 9223407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing antibodies administered before, but not after, virulent SHIV prevent infection in macaques.
    Foresman L; Jia F; Li Z; Wang C; Stephens EB; Sahni M; Narayan O; Joag SV
    AIDS Res Hum Retroviruses; 1998 Aug; 14(12):1035-43. PubMed ID: 9718118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate differences between simian-human immunodeficiency virus (SHIV)(KU-2)-infected rhesus and pig-tailed macaques in development of neurological disease.
    Buch SJ; Villinger F; Pinson D; Hou Y; Adany I; Li Z; Dalal R; Raghavan R; Kumar A; Narayan O
    Virology; 2002 Mar; 295(1):54-62. PubMed ID: 12033765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of antigenic variants of simian immunodeficiency virus (SIVmac) in a seronegative macaque after SIVmac239 infection.
    Chuang LF; Blackbourn DJ; Chuang AJ; Killam KF; Liu X; Li Y; Kung HF; Chuang RY
    Cell Mol Biol Res; 1994; 40(7-8):661-9. PubMed ID: 7787884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivation and biological characterization of a molecular clone of SHIV(KU-2) that causes AIDS, neurological disease, and renal disease in rhesus macaques.
    Liu ZQ; Muhkerjee S; Sahni M; McCormick-Davis C; Leung K; Li Z; Gattone VH; Tian C; Doms RW; Hoffman TL; Raghavan R; Narayan O; Stephens EB
    Virology; 1999 Aug; 260(2):295-307. PubMed ID: 10417264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic and biological alteration of a human immunodeficiency virus type 1 (HIV-1)-simian immunodeficiency virus strain mac chimera, with HIV-1 Env, recovered from a long-term carrier monkey.
    Igarashi T; Kuwata T; Takehisa J; Ibuki K; Shibata R; Mukai R; Komatsu T; Adachi A; Ido E; Hayami M
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1649-58. PubMed ID: 8760411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.
    Kumar A; Lifson JD; Silverstein PS; Jia F; Sheffer D; Li Z; Narayan O
    Virology; 2000 Aug; 274(1):149-64. PubMed ID: 10936096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac.
    Naidu YM; Kestler HW; Li Y; Butler CV; Silva DP; Schmidt DK; Troup CD; Sehgal PK; Sonigo P; Daniel MD
    J Virol; 1988 Dec; 62(12):4691-6. PubMed ID: 2846880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte-tropic simian immunodeficiency virus causes persistent infection in the brains of rhesus monkeys.
    Stephens EB; Liu ZQ; Zhu GW; Adany I; Joag SV; Foresman L; Berman NE; Narayan O
    Virology; 1995 Nov; 213(2):600-14. PubMed ID: 7491784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the pathogenic KU-SHIV model of acquired immunodeficiency syndrome in macaques.
    Joag SV; Li Z; Foresman L; Pinson DM; Raghavan R; Zhuge W; Adany I; Wang C; Jia F; Sheffer D; Ranchalis J; Watson A; Narayan O
    AIDS Res Hum Retroviruses; 1997 May; 13(8):635-45. PubMed ID: 9168232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a neutralization-escape variant of SHIVKU-1, a virus that causes acquired immune deficiency syndrome in pig-tailed macaques.
    Narayan SV; Mukherjee S; Jia F; Li Z; Wang C; Foresman L; McCormick-Davis C; Stephens EB; Joag SV; Narayan O
    Virology; 1999 Mar; 256(1):54-63. PubMed ID: 10087226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of a primary isolate-like virus from simian and human immunodeficiency virus-infected macaque having broad neutralizing activity.
    Miyazaki Y; Kuwata T; Takehisa J; Hayami M
    AIDS Res Hum Retroviruses; 2002 Apr; 18(6):469-75. PubMed ID: 11958690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralization sensitivity of cell culture-passaged simian immunodeficiency virus.
    Means RE; Greenough T; Desrosiers RC
    J Virol; 1997 Oct; 71(10):7895-902. PubMed ID: 9311879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.